PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $74,000 | +37.0% | 21,800 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $54,000 | +10.2% | 21,800 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $49,000 | +6.5% | 21,800 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $46,000 | -37.0% | 21,800 | 0.0% | 0.01% | -37.5% |
| Q3 2016 | $73,000 | +7.4% | 21,800 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $68,000 | -6.8% | 21,800 | 0.0% | 0.01% | -11.1% |
| Q1 2016 | $73,000 | -5.2% | 21,800 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $77,000 | -30.0% | 21,800 | 0.0% | 0.01% | -35.7% |
| Q3 2015 | $110,000 | -21.4% | 21,800 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $140,000 | -8.5% | 21,800 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $153,000 | -8.9% | 21,800 | 0.0% | 0.02% | -11.1% |
| Q4 2014 | $168,000 | +3.1% | 21,800 | -0.3% | 0.02% | 0.0% |
| Q3 2014 | $163,000 | -23.1% | 21,866 | 0.0% | 0.02% | -18.2% |
| Q2 2014 | $212,000 | +17.1% | 21,866 | +0.3% | 0.02% | +10.0% |
| Q1 2014 | $181,000 | -1.6% | 21,800 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $184,000 | +5.7% | 21,800 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $174,000 | +3.6% | 21,800 | 0.0% | 0.02% | 0.0% |
| Q2 2013 | $168,000 | – | 21,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |